Small molecules designed to rescue wtp53 function have emerged as a potentially promising strategy to circumvent the proliferative and anti-apoptotic advantages gained through loss of p53 tumor suppressor function in different types of cancer [24–26], including gliomas [27, 28]. The gene discussed is TP53; the disease is neoplasm.